Dwarfism Pituitary

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2012-08-14
EMA Withdrawn: Valtropin (somatropin) — BioPartners GmbH
Valtropin (somatropin) by BioPartners GmbH has been withdrawn from the market.